Biofil Chemicals & Pharmaceuticals MD, chairman, board of directors and AGM
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.04.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 97.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,19251.9% delivered
Biofil Chemicals & Pharmaceuticals board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorKETAN SHAHRelated to the promoter
- Company Secretary and Compliance OfficerApoorv Jain
6 directors3 independent1 executive2 non-executive
- KETAN SHAH · Chairperson and managing directorExecutive · joined Aug 2020 · 1 listed board
- SATISH BEOHARIndependent · joined Jun 2021 · reappointed Jun 2021 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats
- ASHOK KUMAR RAMAWATIndependent · joined Aug 2020 · reappointed Aug 2025 · 70 months as independent · 1 listed board · 1 as independent · 2 committee seats
- GAYATRI PADIYARIndependent · joined Aug 2023 · reappointed Aug 2023 · 34 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- MEET SHAHNon-executive · joined Dec 2024 · 1 listed board
- SMITESH SHAHNon-executive · joined Aug 2025 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- RAMESH SHAH, left 11 Mar 2025: Others
- ROMIL SHAH, left 27 Nov 2024: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 May 20266 of 6 present3 independent · 105 days in between
- 13 Feb 20266 of 6 present3 independent
Audit Committee
Chair GAYATRI PADIYAR
ASHOK KUMAR RAMAWAT, SATISH BEOHAR
- 30 May 20263 of 3 present3 independent · 105 days in between
- 13 Feb 20263 of 3 present3 independent
Nomination and remuneration committee
Chair GAYATRI PADIYAR
ASHOK KUMAR RAMAWAT, SATISH BEOHAR
- 30 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair GAYATRI PADIYAR
ASHOK KUMAR RAMAWAT, SATISH BEOHAR
- 30 May 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- MAHESHWARI & GUPTAPeer-review certificate valid to Aug 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Biofil Chemicals & Pharmaceuticals AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Biofil Chemicals & Pharmaceuticals share news and announcements
Annual general meeting, 23 Sep 2026
25,125 shareholders on the register on 16 Sep 2026; present: 11 promoters and 31 others; votes counted by DARSHIKA WANKHEDE Practicing Company Secretary / DARSHIKA WANKHEDE.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.13% · promoters 97.52% · institutions 0.00% · other public 14.11%
- To appoint a Director in place of Mr. Smitesh Shah (DIN: 00326182) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.98% · promoters 95.07% · institutions 0.00% · other public 14.11%
- Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company on attaining the age of 75 (seventy-five) years.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.13% · promoters 97.52% · institutions 0.00% · other public 14.11%
- Approval of Material Related Party Transaction(s) with Cyano Pharma Private Limited.OrdinaryPromoters have an interest in it99.96% for0.04% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 0.31% · promoters 0.00% · institutions 0.00% · other public 0.58%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2025, 8 resolutions
25,641 shareholders on the register on 20 Sep 2025; present: 13 promoters and 38 others; votes counted by L.N. JOSHI / L.N. JOSHI & Company.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- To appoint a Director in place of Mr. Meet Shah (DIN: 06578351) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- To appoint Joshi Sahay and Company, Practicing Company Secretaries as the Secretarial Auditor of the Company and fix their remunerationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- Re-appointment of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non Executive Independent Director of the Company for a second term of five years:Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- Re-appointment of Mr. Satish Beohar (DIN: 09220291) as a Non Executive Independent Director of the Company for a second term of five years:Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- Approval of Material Related Party Transaction(s) with Cyano Pharma Private LimitedOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 8.14% · promoters 0.00% · institutions 0.00% · other public 15.32%
- Change in designation of Mr. Ketan Shah (DIN: 08818212) from Whole Time Director to Chairman and Managing Director.SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
- CONFIRMATION OF APPOINTMENT OF MR. SMITESH SHAH (DIN: 00326182) AS A DIRECTOR UNDER THE CATEGORY OF PROMOTER NON EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANY.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 52.05% · promoters 93.83% · institutions 0.00% · other public 15.32%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 13 Sep 2025, 1 resolution
25,845 shareholders on the register on 8 Aug 2025; votes counted by L.N. JOSHI / L.N. Joshi & Company.The company's voting result (opens in a new tab)
TO SELL, TRANSFER OR OTHERWISE DISPOSE OF ONLY LEASEHOLD RIGHTS IN RESPECT OF VACANT PORTION OF INDUSTRIAL LAND ABOUT 80156 SQUARE METER SITUATED AT PLOT NO. 8, SECTOR-3, KHEDA INDUSTRIAL ESTATE, PITHAMPUR, DIST. DHAR (M.P.) (AS PERMITTED BY MPAKVN)MoreLess
Special99.93% for0.07% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 55.19% · promoters 100.00% · institutions 0.00% · other public 15.76%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 21 Mar 2025, 3 resolutions
26,364 shareholders on the register on 14 Feb 2025; votes counted by L. N. Joshi / L.N. JOSHI & COMPANY.The company's voting result (opens in a new tab)
- CONFIRMATION OF APPOINTMENT OF MR. MEET SHAH (DIN: 06578351) AS A DIRECTOR UNDER THE CATEGORY OF PROMOTER NON EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANYOrdinaryPromoters have an interest in it99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 8.24% · promoters 0.00% · institutions 0.00% · other public 15.52%
SALE, TRANSFER OR OTHERWISE DISPOSE OF PLANT & MACHINERIES, FURNITURE, FIXTURES, SCRAPS, STRUCTURE, TOOLS, MANUFACTURING EQUIPMENTS AND OTHER ASSETS EXCEPT LEASEHOLD LAND AND BUILDING SITUATED AT 11/12, SECTOR 'E', SANWER ROAD INDUSTRIAL AREA, INDORE M.P. TO CYANO PHARMA PRIVATE LIMITED (RELATED PARTY)MoreLess
OrdinaryPromoters have an interest in it99.97% for0.03% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 8.24% · promoters 0.00% · institutions 0.00% · other public 15.52%
- SALE, TRANSFER OR OTHERWISE DISPOSE OF ONLY LEASEHOLD LAND RIGHT & BUILDING SITUATED AT 11/12, SECTOR 'E', SANWER ROAD INDUSTRIAL AREA, INDORE M.P. TO FORMO PLAST PRIVATE LIMITED (RELATED PARTY)OrdinaryPromoters have an interest in it99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 8.24% · promoters 0.00% · institutions 0.00% · other public 15.52%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 30 Sep 2024, 5 resolutions
Present: 13 promoters and 29 others.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 52.34% · promoters 92.81% · institutions 0.00% · other public 16.75%
- To appoint a Director in place of Mr. Romil Shah (DIN: 00326110) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 52.34% · promoters 92.81% · institutions 0.00% · other public 16.75%
- Approval of Material Related Party Transaction(s) with Cyano Pharma Private LimitedOrdinaryPromoters have an interest in it99.96% for0.04% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 8.89% · promoters 0.00% · institutions 0.00% · other public 16.75%
- Approval for Loan, Guarantee or Investments in excess of the prescribed limits under Section 186 of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 52.34% · promoters 92.81% · institutions 0.00% · other public 16.75%
- Disposal of Undertaking situated at 11/12, Sector 'E', Sanwer Road Industrial Area, Indore – 452015 Madhya Pradesh to Cyano Pharma Private Limited, (Related Party)OrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 8.89% · promoters 0.00% · institutions 0.00% · other public 16.75%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 15 Mar 2024, 1 resolution
The company's voting result (opens in a new tab)
- DISPOSAL OF UNDERTAKING SITUATED AT 11/12, SECTOR 'E', SANWER ROAD INDUSTRIAL AREA, INDORE – 452015 MADHYA PRADESHSpecial99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 51.33% · promoters 90.90% · institutions 0.00% · other public 16.52%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2023, 5 resolutions
Present: 15 promoters and 33 others.The company's voting result (opens in a new tab)
- TO CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENT OF THE COMPANY TOGETHER WITH THE REPORT OF THE BOARD OF DIRECTORS AND THE AUDITORS THEREON FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 56.24% · promoters 100.00% · institutions 0.00% · other public 17.76%
TO APPOINT A DIRECTOR IN PLACE OF MR. KETAN SHAH WHOLE TIME DIRECTOR OF THE COMPANY, WHO RETIRES BY ROTATION IN TERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE OFFERS HIMSELF FOR RE-APPOINTMENTMoreLess
OrdinaryPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 56.24% · promoters 100.00% · institutions 0.00% · other public 17.76%
- RE-APPOINTMENT OF MR. KETAN SHAH AS WHOLE TIME DIRECTOR OF THE COMPANYSpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 9.43% · promoters 0.00% · institutions 0.00% · other public 17.76%
- APPOINTMENT OF MRS. GAYATRI PADIYAR (DIN: 10260173) AS A NON EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANYSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 56.24% · promoters 100.00% · institutions 0.00% · other public 17.76%
- APPROVAL OF MATERIAL RELATED PARTY TRANSACTION(S) WITH CYANO PHARMA PRIVATE LIMITEDOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 9.43% · promoters 0.00% · institutions 0.00% · other public 17.76%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 30 Sep 2022, 4 resolutions
Present: 14 promoters and 29 others.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Financial Statement of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2022.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 56.39% · promoters 100.00% · institutions 0.00% · other public 18.02%
To appoint a Director in place of Mr. Romil Shah (DIN: 00326110) Non executive Non Independent Director of the Company, who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment.MoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 9.57% · promoters 0.00% · institutions 0.00% · other public 18.02%
- RE-APPOINTMENT OF M/SMAHESHWARI & GUPTA, CHARTERED ACCOUNTANTS AS STATUTORY AUDITORSnOF THE COMPANY AND TO FIX THEIR REMUNERATION.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 56.39% · promoters 100.00% · institutions 0.00% · other public 18.02%
- APPROVAL OF MATERIAL RELATED PARTY TRANSACTION(S) WITH CYANO PHARMA PRIVATE LIMITED.OrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 9.57% · promoters 0.00% · institutions 0.00% · other public 18.02%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.